Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy-Reference-Cited by-同舟云学术

Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy

Published:2022-05 Issue:5 Volume:40 Page:197.e1-197.e9
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Piao Xuan-Mei^ORCID,Kim Yeong Uk^ORCID,Byun Young Joon,Zheng Chuang-Ming,Moon Sung Min,Kim Kyeong,Lee Hee Youn,Jeong Pildu,Kang Ho Won,Kim Won Tae,Lee Sang-Cheol,Kim Wun-Jae,Yun Seok Joong

Funder

Kyungpook National University Hospital

Chonbuk National University Hospital

Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference35 articles.

1. European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update;Babjuk;Eur Urol,2019

2. Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect;Han;Biomed Pharmacother,2020

3. EORTC Nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non–muscle-invasive stage Ta–T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus calmette-guérin;Cambier;Eur Urol,2016

4. Predicting response to intravesical Bacillus Calmette-Guérin immunotherapy: are we there yet? A systematic review;Kamat;Eur Urol,2018

5. Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder;Xylinas;Br J Cancer,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribosomal Protein L9 Maintains Stemness of Colorectal Cancer via an ID-1 Dependent Mechanism;Journal of Cancer Prevention;2024-06-30

2. Prostate cancer resistance leads to a global deregulation of translation factors and unconventional translation;NAR Cancer;2022-09-28

3. Comparison of Anticancer Activities and Biosafety Between Salmonella enterica Serovar Typhimurium ΔppGpp and VNP20009 in a Murine Cancer Model;Frontiers in Microbiology;2022-06-29